KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Ginkgo Bioworks Holdings (DNA) Receivables - Other (2021 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Receivables - Other for 4 consecutive years, with $1.6 million as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Receivables - Other fell 58.47% year-over-year to $1.6 million, compared with a TTM value of $1.6 million through Mar 2023, down 58.47%, and an annual FY2021 reading of $4.6 million, down 11.78% over the prior year.
  • Receivables - Other was $1.6 million for Q1 2023 at Ginkgo Bioworks Holdings, down from $2.1 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $6.5 million in Q2 2022 and bottomed at $300000.0 in Q2 2021.
  • Average Receivables - Other over 4 years is $3.4 million, with a median of $3.8 million recorded in 2022.
  • The sharpest move saw Receivables - Other skyrocketed 2066.67% in 2022, then tumbled 58.47% in 2023.
  • Year by year, Receivables - Other stood at $5.2 million in 2020, then fell by 11.78% to $4.6 million in 2021, then crashed by 54.44% to $2.1 million in 2022, then decreased by 24.39% to $1.6 million in 2023.
  • Business Quant data shows Receivables - Other for DNA at $1.6 million in Q1 2023, $2.1 million in Q3 2022, and $6.5 million in Q2 2022.